Circulating tumor cells: a window into cancer biology and metastasis
Section snippets
References and recommended reading
Papers of particular interest, published within the period of review, have been highlighted as:
• of special interest
•• of outstanding interest
References (17)
- et al.
High speed detection of circulating tumor cells
Biosens Bioelectron
(2006) - et al.
In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry
Proc Natl Acad Sci U S A
(2007) - et al.
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
N Engl J Med
(2004) - et al.
The basics of epithelial–mesenchymal transition
J Clin Invest
(2009) - et al.
Stem cells, cancer, and cancer stem cells
Nature
(2001) - et al.
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
Clin Cancer Res
(2004) - et al.
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nature
(2007) - et al.
Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells
Biotechnol Bioeng
(2009)
Cited by (271)
Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications
2023, Biomedicine and PharmacotherapyThymosin α1 interacts with Galectin-1 modulating the β-galactosides affinity and inducing alteration in the biological activity
2023, International ImmunopharmacologyDevelopmental genes: the bridge between development and cancer metastasis
2022, Unraveling the Complexities of Metastasis: Transition from a Segmented View to a Conceptual ContinuumCirculating tumor cell detection methods in renal cell carcinoma: A systematic review
2021, Critical Reviews in Oncology/HematologyCitation Excerpt :These are extremely rare compared to whole blood cells, with an estimated CTCn of one CTC per billion normal blood cells in metastatic cancer patients.( Maheswaran and Haber, 2010) Additionally, a proportion of these cells is lost during sample processing, making their detection difficult and utterly reliant on the sensitivity and specificity of the methods used.( Bankó et al., 2019) Furthermore, the lack of specific RCC molecular markers has hindered CTC research in this tumor compared to other epithelial tumors.(
The value of circulating tumor cells with positive centromere probe 8 in the diagnosis of small pulmonary nodules
2021, Translational OncologyCitation Excerpt :These CTCs are also recognized as an acceptable non-invasive tool for early cancer diagnosis, evaluation, and progression. The study of CTCs began more than a hundred year ago; however, advancements in the development and use of CTCs for diagnosis or prognosis have only emerged in recent years [11,12]. Currently, CellSearchⓇ is the only method approved by the US Food and Drug Administration (FDA) for clinical determination of CTCs, although various methods and technologies are used in academic studies and clinical diagnosis [13].
Colorimetric detection of immunomagnetically captured rare number CTCs using mDNA-wrapped single-walled carbon nanotubes
2021, Biosensors and Bioelectronics